DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis

BACKGROUND: It is still an unmet clinical need to identify potent biomarkers for immunotherapy on patients with lung squamous cell carcinoma (LUSC). METHODS: In this study, we explored the differentially expressed genes (DEGs) that were simultaneously correlated with four pathways (i.e. CD8(+)αβT ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liling, Xie, Tongji, Zhao, Fuqiang, Feng, Yu, Zhu, Haohua, Tang, Le, Han, Xiaohong, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617027/
https://www.ncbi.nlm.nih.gov/pubmed/36317140
http://dx.doi.org/10.1155/2022/6512300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617027/
https://www.ncbi.nlm.nih.gov/pubmed/36317140
http://dx.doi.org/10.1155/2022/6512300

Ejemplares similares